+ Site Statistics
+ Search Articles
+ Subscribe to Site Feeds
Most Shared
PDF Full Text
+ PDF Full Text
Request PDF Full Text
+ Follow Us
Follow on Facebook
Follow on Twitter
Follow on LinkedIn
+ Translate
+ Recently Requested

Incidence and Risk Factors of Cholangitis after Hepaticojejunostomy

Incidence and Risk Factors of Cholangitis after Hepaticojejunostomy

Journal of Gastrointestinal Surgery 22(4): 676-683

After hepatobiliary-pancreatic surgery, hepaticojejunostomy cholangitis is a rare condition; the true incidence rate of postoperative cholangitis is unknown. Therefore, our study aimed to determine the incidence rate and timing of postoperative cholangitis after biliary-enteric anastomosis, and to evaluate risk factors and management strategies. Our single-center retrospective study included 583 patients who had undergone biliary-enteric anastomosis for hepatobiliary-pancreatic diseases. Demographic and treatment data were extracted from the medical records, and the association between potential risk factors and the development of postoperative cholangitis evaluated using a prospectively collected database. Postoperative cholangitis developed in 45/583 patients (incidence rate, 7.7%), on average 18.3 ± 27.4 months (median = 6.9 months) after surgery. On multivariate analysis, the following factors were independently associated with postoperative cholangitis after biliary-enteric anastomosis: male sex, benign condition, and postoperative complication with a Clavien-Dindo classification grade > III. Among patients with postoperative cholangitis, a biliary stricture developed in 57.8% (26/45) of cases. Percutaneous balloon dilatation (73.1%) and endoscopic stenting (11.5%) were used as initial treatment of the stricture, with surgical revision being required in only 15.4% of cases of hepaticojejunostomy stricture. Biliary-enteric anastomotic cholangitis after hepaticojejunostomy is a distinct disease process. Although non-operative management of postoperative cholangitis is successful in many cases, further research is required to better understand patient- and physician-related factors that predispose patients to postoperative cholangitis.

(PDF emailed within 0-6 h: $19.90)

Accession: 065230634

Download citation: RISBibTeXText

PMID: 29273998

DOI: 10.1007/s11605-017-3532-9

Related references

Incidence and risk factors for anastomotic stenosis of continuous hepaticojejunostomy after pancreaticoduodenectomy. Journal of Hepato-Biliary-Pancreatic Sciences 23(10): 628-635, 2016

Risk factors and incidence of acute pyogenic cholangitis. Hepatobiliary and Pancreatic Diseases International 11(6): 650-654, 2013

Risk factors and incidence of acute pyogenic cholangitis. Hepatobiliary & Pancreatic Diseases International 11(6): 650-654, 2012

Incidence and risk factors for cholangiocarcinoma in primary sclerosing cholangitis. American Journal of Gastroenterology 99(3): 523-526, 2004

Incidence of hepaticojejunostomy stricture after hepaticojejunostomy. Surgery 160(3): 691-698, 2017

Cholangitis and liver abscess after percutaneous ablation therapy for liver tumors: incidence and risk factors. Journal of Vascular and Interventional Radiology 14(12): 1535-1542, 2003

An investigative technique to distinguish between the gastrojejunostomy and the hepaticojejunostomy as the cause of cholangitis following pancreaticoduodenectomy. Annals of the Royal College of Surgeons of England 90(5): 433, 2008

Risk factors of postoperative anastomotic stricture after excision of choledochal cysts with hepaticojejunostomy. Journal of Gastrointestinal Surgery 12(5): 822-828, 2007

Hepaticojejunostomy--analysis of risk factors for postoperative bile leaks and surgical complications. Journal of Gastrointestinal Surgery 11(5): 555-561, 2007

The relationship between a subcutaneously placed afferent jejunal loop in a hepaticojejunostomy and postoperative cholangitis. International Surgery 74(3): 167-170, 1989

Volvulus of the Roux-en-Y hepaticojejunostomy. A rare complication manifested by recurrent ascending cholangitis. International Surgery 79(2): 176-177, 1994

Cholangitis caused by Roux-en-Y hepaticojejunostomy obstruction by a biliary stone after liver transplantation. Transplantation 75(3): 416-418, 2003

Immunoglobulin G4-associated cholangitis mimicking cholangiocarcinoma treated by laparoscopic choledochectomy with intracorporeal Roux-en-Y hepaticojejunostomy. World Journal of Surgical Oncology 12: 363, 2015

Jejunal loop obstruction by a gallstone from hepaticojejunostomy-induced acute cholangitis: report of a case. Surgery Today 36(8): 737-740, 2006

Could recurrent cholangitis after Roux-en-Y hepaticojejunostomy be explained by motor intestinal anomalies? A manometric study. American Journal of Gastroenterology 86(9): 1255-1258, 1991